Phosphorex is teaming up with notable partners for a virtual panel aimed at enhancing targeted lipid nanoparticle development. Don't miss this opportunity for insightful discussions!

Phosphorex has appointed John Rigg as Chairman of the Board, enhancing its leadership to meet growing drug delivery needs in the pharmaceutical industry.

Phosphorex announces the appointment of Jerry Williamson as CEO, bringing extensive experience in bioscience to enhance drug delivery technology.

The formation of the LNP Alliance, featuring Phosphorex, NOF Corporation, and others, aims to revolutionize lipid nanoparticle technology and drug development.

Wednesday, July 29, 2026 | 12:00 PM EDT / 5:00 PM BST / 6:00 PM CEST HOPKINTON, Mass., June 24, 2026 /PRNewswire/ -- Along with fellow LNP Alliance members, NOF Corporation and Neosome Life Sciences, Phosphorex is hosting a free, one-hour virtual discussion entitled, "Streamline Targeted...

HOPKINTON, Mass., June 2, 2026 /PRNewswire/ -- Phosphorex, a drug delivery-focused CDMO specializing in lipid nanoparticles, polymeric nanoparticles, and polymeric microspheres, has named John Rigg Chairman of its Board of Directors. Rigg joined the Phosphorex board in 2024 and has since...

HOPKINTON, Mass., Aug. 13, 2025 /PRNewswire/ -- Phosphorex, a drug delivery-focused contract development and manufacturing organization ("CDMO") and Ampersand Capital Partners portfolio company announced today the appointment of Jerry Williamson as Chief Executive Officer. With over 35...

HOPKINTON, Mass., May 8, 2025 /PRNewswire/ -- In a groundbreaking collaboration, Phosphorex, NOF CORPORATION, NeoSome Life Sciences, NanoImaging Services (NIS), and Envol Biomedical have joined forces to establish the LNP Alliance, a strategic partnership dedicated to advancing lipid...